[Treatment of Hansen's disease with delayed-action sulfamides].
D000085:Acetates / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D005500:Follow-Up Studies; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use; D013412:Sulfadimethoxine / Q000627:therapeutic use; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000097:blood / Q000627:therapeutic use*
D000085:Acetates; D003692:Delayed-Action Preparations; D011743:Pyrimidines; D013449:Sulfonamides; D013412:Sulfadimethoxine; D013421:Sulfamethoxypyridazine
Traitement de la maladie de Hansen par les sulfamides-retard.